Clinical Trials Browser

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Gastrointestinal Neoplasms, Melanoma, Neoplasm Metastasis, Pancreatic Neoplasms, Sarcoma, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT04206891 2025-12-04

CDH1 Germline Mutations in Lobular Breast Cancer

Completed

421 enrolled

Carcinoma, Lobular

NCT05410951 2025-12-04

LobularCard

Active not recruiting

800 enrolled

Breast

Breast Carcinoma In Situ, Carcinoma, Lobular

NCT05919108 2025-09-09

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

Phase 2 Recruiting

30 enrolled

Carcinoma, Lobular

NCT05463796 2025-08-07

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Recruiting

5,000 enrolled

GastrointestinalGynecologicOther hematologic neoplasmThoracic

Barrett Esophagus, Carcinoma in Situ, Endometrial Hyperplasia, Fibrosis, Giant Cell Tumors, Lung Neoplasms, Osteochondroma, Carcinoma, Lobular, Nevus, Epithelioid and Spindle Cell, Hematologic Neoplasms, Non-alcoholic Fatty Liver Disease

NCT00898508 2025-06-25

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

Completed

563 enrolled

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT01819233 2025-06-06

CAREFOR

Phase NA Completed

38 enrolled 10 charts

Breast

Breast Carcinoma In Situ, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Carcinoma, Ductal, Breast, Carcinoma, Lobular

NCT04252859 2025-05-18

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Phase 2 Terminated

44 enrolled 15 charts

Carcinoma, Lobular

NCT02764541 2025-05-07

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Phase 2 Active not recruiting

195 enrolled 26 charts

Breast

Breast Neoplasms, Carcinoma, Lobular

NCT06067503 2025-04-22

Biomarkers to Detect Endocrine Therapy Resistance

Phase 2 Recruiting

8 enrolled

Breast

Breast Neoplasms, Neoplastic Cells, Circulating, Neoplasm Metastasis, Carcinoma, Lobular

Clinical Trials

Improving Survival for Metastatic Lobular Breast Cancer (PLUMB Registry)

A Study Comparing Cancer Imaging Approaches in People With Lobular Breast Cancer

[68Ga]Ga DOTA-5G as a Diagnostic Imaging Agent for Metastatic/Advanced Invasive Lobular Breast Cancer (LBC)

[18F]FPyQCP PET Imaging of Fibroblast Activation Protein in Selected Oncology Indications

Hypofractionated Radiation Therapy After Mastectomy in Preventing Recurrence in Patients With Stage IIa-IIIa Breast Cancer

GALILEE

Fulvestrant and/or Anastrozole in Treating Postmenopausal Patients With Stage II-III Breast Cancer Undergoing Surgery

LBC-Monitor

FAPI-CL

Phase II Study of REPotrectinib With or Without Fulvestrant in Patients With Hormone Receptor-positive Human Epidermal Growth Factor 2-negative Metastatic Invasive LObular Carcinoma Who Received a Prior Endocrine Therapy in Combination With Cyclin-dependent Kinase 4 and 6 Inhibitor (REPLOT Trial)

A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue

CDH1 Germline Mutations in Lobular Breast Cancer

LobularCard

Neoadjuvant Neratinib in Stage I-III HER2-Mutated Lobular Breast Cancers

InAdvance: Surveillance, Prevention, and Interception in a Population at Risk for Cancer

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

CAREFOR

[18F]Fluoroestradiol-PET/CT Imaging of Invasive Lobular Carcinoma

Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

Biomarkers to Detect Endocrine Therapy Resistance